RECRUITING

The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

Talk to us

Conditions

COVID-19Breath testingNasal swab

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The type and number of chemicals in exhaled breath are different in people with infection as compared to those without infection. In this study, the breath of people with and without COVID infection will be measured. Changes in the amount and type of chemicals in breath will be used to determine if an individual does or does not have COVID infection. If the measurements of breath are a reliable measure of COVID infection, this device may be used to rapidly screen people who are attending large public events (for example, music concert or baseball game) to minimize the spread of COVID at the event.

Official Title

Identification of COVID-19 Infection from Measurement of Exhaled Breath

Quick Facts

Study Start:2024-08-19
Study Completion:2025-02-26
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06571136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Subject must complete the consent process
  2. 2. Subjects of both sexes must be ≥ 18 and ≤ 70 years old
  3. 3. Control subjects must have negative RT-PCR and antigen test
  4. 4. COVID subjects must have a positive RT-PCR and/or antigen test.
  1. 1. Subjects with severe lung disease which would prevent them from providing a breath sample through a large bore tube (e.g., large drinking straw)
  2. 2. Subjects with uncontrolled diabetes (e.g., ketoacidosis)
  3. 3. Subjects who are routinely exposed to paints, paint thinners, gasoline, varnishes, glues, dry cleaning solvents, or industrial cleaning products
  4. 4. Subjects who are daily smokers of cigarettes, e-cigarettes, tobacco products, or marijuana
  5. 5. Subjects who have consumed alcohol in the previous 24 hours
  6. 6. Have not consumed large amounts of garlic (38 grams) over the prior 24 hours. This amount of garlic can come from approximately 6 garlic cloves or garlic supplement capsules,
  7. 7. Subjects who are experiencing respiratory failure

Contacts and Locations

Study Contact

Becca Watson, BS
CONTACT
(425) 261-3547
beccawatson@providence.org

Study Locations (Sites)

Providence Regional Medical Center Everett
Everett, Washington, 98201
United States

Collaborators and Investigators

Sponsor: N5 Sensors

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-19
Study Completion Date2025-02-26

Study Record Updates

Study Start Date2024-08-19
Study Completion Date2025-02-26

Terms related to this study

Keywords Provided by Researchers

  • Breath testing
  • COVID-19
  • Nasal swab

Additional Relevant MeSH Terms

  • COVID-19